Created On: 2020-07-15
Record Count: 3
- Drug Discovery
IPSCIO Report Record List
Below you will find the records curated into this collection. This summary includes the complete licensed property description so that you can review and determine if this collection covers the topics, technology or transaction type that is relevant for your needs. The full report will include all relevant deal data such as the royalty base, agreement date, term description, royalty rates and other deal terms. For reference, here is a sample of a full IPSCIO curated royalty rate report: Sample Report
IPSCIO Record ID: 3402
Licensed Products shall mean all assays, kits, compositions, reagents used in assays, and Diagnostic Instruments for performing assays where Licensee realizes a profit on cumulative Net Sales of such Diagnostic Instruments, which relate to RNA-based amplification/detection systems which employ exponential amplification of replicative RNA by QB Replicase or a related enzyme, whether or not used in or on Diagnostic Instruments, and which are covered by a claim of a Licensed Patent that has neither expired nor been declared invalid by a court of last resort (Issued Valid Claim), or which use Licensed Research Information. Licensed Products shall exclude reusable physical structures such as, by way of example, containment, filters, detection means, temperature control elements, transport mechanisms, sonication means, mixing elements, film software, computing hardware, manuals, recording devices, paper and packing.
IPSCIO Record ID: 7119
(b) U.S. Serial No. 08/006,073 entitled Sensitive Nucleic Acid Sandwich Hybridization Assays And Kits by Tyagi et al., filed January 15, 1993 and otherwise designated as A38 by PHRI; and
(c) U.S. Serial No. 08/005,893 entitled Diagnostic Assays And Kits For RNA Using RNA Binary Probes And A Ribozyme Ligase by Lizardi et al., filed January 15, 1993 and otherwise designated as A39 by PHRI.
IPSCIO Record ID: 237263
Licensor grants a world-wide, non-exclusive, nontransferable license, without the right to sublicense, to make, use, sell, off er for sale and import Licensed Products for genotyping HAPâ„¢ Markers in all fields other than human and animal infectious diseases. Excluded from this grant is the right to make, sell, offer for sale or import the Licensors ProbeTecâ„¢ ET.
The patents include, but are not limited to, Nucleic Acid Target Generation, Oligonucleotides for amplification and detection of hemochromatosis, and, Methods for detecting nucleic acid sequence variations.
Licensed Products shall mean any device, instrument, service, kit, composition of matter, material, product or component thereof that utilizes Licensed Know-How.
Instrument shall mean the Licensors ProbeTecâ„¢ ET installed in Licensees HAPâ„¢ Typing facility in New Haven, CT.
HAPâ„¢ Marker shall mean a polymorphism or any ordered combination of two or more polymorphisms present at a locus on a single chromosome that is contained in the Licensee HAPâ„¢ Database during the term of this Agreement or that is discovered from any gene where such discovery was made solely by employees of Licensee or others acting on behalf of Licensee, or, jointly by employees of Licensees or others acting on its behalf and employees of a HAPâ„¢ Partner or others acting on its behalf or for which a HAPâ„¢ Partner requests Licensee to develop genotyping assays or provide genotype data.
Licensor ProbeTecâ„¢ ET shall mean the clinical platform for infectious disease testing owned by Licensor using Strand Displacement Amplification Technology or SDA Technology and real time detection means.
1. US Patent No. 5,270,184, entitled 'Nucleic Acid Target Generation'
2. US Patent No. 5,422,252, entitled 'Simultaneous Amplification of Multiple Targets'
3. US Patent No. 5,455,166, entitled 'Strand Displacement Amplification'
4. US Patent No. 5,536,649, entitled 'Decontamination of Nucleic Acid Amplification Reactions'
5. US Patent No. 5,547,861, entitled 'Detection of nucleic acid amplification'
6. US Patent No. 5,648,211, entitled 'Strand Displacement Amplifcation Using Thermophilic Enzymes'
7. US Patent No. 5,624,825, entitled 'Simultaneous Amplification of Multiple Targets'
8. US Patent No. 5,691,145, entitled 'Detection of nucleic acids using G-quartets'
9. US Patent No. 5,712,124, entitled 'Strand Displacement Amplification'
10. US Patent No. 5,736,365 entitled 'Multiplex nucleic acid amplification'
11. US Patent No. 5,744,311 entitled 'Strand displacement amplification using thermophilic enzymes'
12. US Patent No. 5,840,487, entitled 'Internal controls for isothermal nucleic acid amplification reactions'
13. US Patent No. 5,863,736, entitled 'Method, apparatus and computer program products for determining quantities of nucleic acid sequences in samples'
14. US Patent No. 5,888,739, entitled 'Detection of nucleic acids using G-quartets and Itetraplexes'
15. US Patent No. 5,916,779, entitled 'Strand displacement amplification of RNA
16. US Patent No. 5,919,630, entitled 'Detection of nucleic acids by fluorescence quenching'
17. US Patent No. 5,928,869, entitled 'Detection of nucleic acids by fluorescence quenching'
18. US Patent No. 5,935,791, entitled 'Detection of nucleic acids by fluorescence quenching'